How you can help

Support routine immunisation

By improving access to vaccines for millions of the most vulnerable children, Gavi is transforming the lives of individuals, helping to boost the economies of lower-income countries and making the world safer for everyone. Help us to reach even more people.

Donate now

 

 

Why support Gavi

Syringe >981 million children immunised
First aid locator >16.2 million future deaths prevented
Transitioned 16 countries transitioned from Gavi support
Billions >185.3 US$ billion in economic benefits for countries (2000–2021)
People 78% of the world's children reached by routine immunisation

Learn more about our work

Facts and figures

Annual progress report

How your organisation can help

Partnering with Gavi

Partnering with Gavi creates an opportunity for private sector partners to join a global alliance. Together, we can save lives, create sustainable socio-economic benefits and take a leading role in global development.

Gavi has secured US$ 14m in match funding, enabling us to effectively double private sector contributions towards the Gavi COVAX AMC. Contributions between US$ 100k and US$ 5m are eligible to be matched. This is a limited term challenge, and will expire on 3 June 2022.

Partner with Gavi

Latest news

View more

28 June 2023

From rabies to hepatitis: Gavi to start rolling out new vaccines to lower-income countries

The pandemic meant several new Gavi vaccine programmes in lower-income countries had to be paused. Following a Board decision this week, these programmes are back on. 

28 June 2023

Global Vaccine Alliance to deploy six-in-one vaccine to lower-income countries, establish innovative mechanisms to protect against future epidemic threats

Gavi’s Board approved new investments in six-in-one (hexavalent) vaccine and approved a long list of potential new vaccines for consideration for inclusion in future Gavi programmes at its Board Meeting, which concluded today 

28 June 2023

New hexavalent vaccines are coming: What impact could they have?

UNICEF expects WHO prequalification of the first whole-cell pertussis hexavalent vaccine during the third quarter of 2023. Here’s how they differ from existing vaccines.

CONTACT

For any questions related to donations, please contact donate@gavi.org.


Please be especially alert to attempts of misleading investment opportunities or crowdfunding platforms that are not connected to Gavi. Gavi, the Vaccine Alliance only accepts individual donations through one of the platforms listed on this page. Gavi, the Vaccine Alliance does not accept any responsibility for or any liability with respect to the use of individual or crowd-sourced donations made through platforms and their corresponding website displaying the Gavi logo, Gavi’s name or otherwise claiming a connection with Gavi that are not listed on this page.

Last updated: 13 Jun 2023

Subscribe to our newsletter